Jeanne Poole, MD, FHRS

Dr. Jeanne Poole is a Professor of Medicine at the University of Washington where she has practiced clinical electrophysiology and had a robust research career. She was the former Section Head of the Arrhythmia/Electrophysiology service for over 20 years. She has been very involved in the Heart Rhythm Society, serving on the Board of Trustees and as the current Editor-In-Chief for the HeartRhythm O2 Journal. She is a noted speaker at conferences both nationally and internationally addressing broad topics of arrhythmia care

Her research career has been focused on the treatment and prevention of arrhythmias, including both atrial and ventricular tachyarrhythmias. She has been a principal investigator (PI) or Co-PI for several large NIH/NHLBI studies: The sudden cardiac death in heart failure trial (SCD-HeFT), the Home automatic defibrillator trial (HAT), and the catheter ablation versus antiarrhythmic drug therapy trial (CABANA). In addition, she has led many other important trials addressing arrhythmia care.

She has been a champion for women with heart disease, promoting the need to enroll adequate numbers of women into clinical trials to fairly understand the benefit of contemporary arrhythmia therapies. As Co-PI of the ongoing BIO\LIBRA trial for which she is the National Co-PI, they were able to enroll 48% women, more than any other trial examining the benefit of implantable defibrillators in patients with heart failure. She is a member of the scientific advisory board for the WomenHeart organization. Dr. Poole has also been a staunch supporter of women seeking a career in Electrophysiology.